Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings
- 1.2k Downloads
Purpose of Review
Here, we review potential causes of muscle dysfunction seen in many patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) such as the effects of oxidative and nitrosative stress (O&NS) and mitochondrial impairments together with reduced heat shock protein production and a range of metabolic abnormalities.
Several studies published in the last few years have highlighted the existence of chronic O&NS, inflammation, impaired mitochondrial function and reduced heat shock protein production in many patients with ME/CFS. These studies have also highlighted the detrimental effects of chronically elevated O&NS on muscle functions such as reducing the time to muscle fatigue during exercise and impairing muscle contractility. Mechanisms have also been revealed by which chronic O&NS and or impaired heat shock production may impair muscle repair following exercise and indeed the adaptive responses in the striated muscle to acute and chronic increases in physical activity.
The presence of chronic O&NS, low-grade inflammation and impaired heat shock protein production may well explain the objective findings of increased muscle fatigue, impaired contractility and multiple dimensions of exercise intolerance in many patients with ME/CFS.
KeywordsChronic fatigue Muscle Cytokines Oxidative Nitrosative Disability
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors
There was no specific financial support for this specific research.
Recently published papers of particular interest have been highlighted as: • Of importance
- 6.Jason LA, McManimen S, Sunnquist M, Brown A, Furst J, Newton JL, et al. Case definitions integrating empiric and consensus perspectives. Fatigue : Biomed, Health Behav. 2016;4(1):1–23.Google Scholar
- 8.• Morris G, Berk M, Galecki P, Walder K, Maes M. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 2015;53(2):1195–219. This paper reviews pathways and abnormalities underpinning the incapacitating fatigue suffered by many people suffering from a range of systemic and neuro-inflammatory disorders including ME/CFS.Google Scholar
- 9.Shan ZY, Kwiatek R, Burnet R, Del Fante P, Staines DR, Marshall-Gradisnik SM, et al. Progressive brain changes in patients with chronic fatigue syndrome: a longitudinal MRI study. J Magn Reson Imaging. 2016.Google Scholar
- 11.Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015;1(1).Google Scholar
- 12.• Russell L, Broderick G, Taylor R, Fernandes H, Harvey J, Barnes Z, et al. Illness progression in chronic fatigue syndrome: a shifting immune baseline. BMC Immunol. 2016;17(1):1–11. This study involved patients diagnosed with ME/CFS according to very narrow criteria and the authors reported longitudinal changes in their immune profile with elevated levels of IL-8 in the recently afflicted but the opposite held in patients ill for more than 2 years. Similarly, early ME/CFS patients displayed low levels of IL-6 but the reverse was true in patients suffering from incapacitating fatigue for over 2 years.Google Scholar
- 17.• Maes M. A new case definition of neuro-inflammatory and oxidative fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or myalgic encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers. Neuro Endocrinol Lett. 2015;36(4):320–9. This paper provides evidence demonstrating that ME/CFS is not a single illness with a unitary pathogenesis and pathophysiology. This paper outlines a new diagnostic schema offering a pathway to selecting a “subgroup ” of CFS patients which could form the basis of testing many of the explanations proposed to underpin the well-documented muscle pathology seen in many patients who have been afforded a CFS diagnosis.Google Scholar
- 19.• Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiomed. 2016;4(1):1–12. This is an important study as it builds on earlier work demonstrating the existence of intestinal dysbiosis in many CFS patients. This is significant as it potentially explains the presence of commensal antigens in the periheral blood of ME/CFS patients repeatedly reported by researchers. The chronic activation of pattern recognition receptors such as TLR-4 by bacterial antigens translocated from the gut could go some way to explaining the presence of activated inflammatory pathways and chronic O&NS in ME/CFS patients diagnosed according to international consensus guidelines.Google Scholar
- 20.• Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). PLoS One. 2015;10(12):e0145453. This study provided an avenue whereby patients with disuse muscle deconditioning could be differentiated from patients with ME/CFS as these changes in the commensal population and plasma LPS levels with exercise have not been reported in the former group of people. This increase in systemic markers of inflammation can also go some way to explaining the phenomenon of a worsening of global symptoms during and in the immediate aftermath of very slight increases in physical activity.Google Scholar
- 22.Maes M, Mihaylova I, Leunis J-C. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut–intestinal permeability. J Affect Disord. 2007;99(1-3):237–40.PubMedCrossRefGoogle Scholar
- 23.• Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M. Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Molec Neurobiol. 2016. This review examines recent studies investigating the adverse effect of dysfunctional nitric oxide signalling effect by reversible S-nitrosylation as a source of pathology. The mechanisms regulating this form of signalling breakdown in an environment of chronic O&NS and such a breakdown could explain in part many of the abnormalities observed in ME/CFS patients in the immunological, autoimmune and bioenergetic domains.Google Scholar
- 24.White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823–36.PubMedPubMedCentralCrossRefGoogle Scholar
- 29.• Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO(2)peak indicates functional impairment. J Transl Med. 2014;12:104. This study shows that repeated cardiopulmonary exercise tests may be employed as a clinical indicator for diagnosing ME/CFS. Moreover, ME/CFS patients are unable to reproduce physiological measures at maximal/ventilatory threshold.Google Scholar
- 31.• Rutherford G, Manning P, Newton JL. Understanding muscle dysfunction in chronic fatigue syndrome. J Aging Res. 2016;2016:2497348. Another mechanism that may explain muscle fatigue in patients with ME/CFS is the overutilisation of the lactate dehydrogenase pathway and slowed acid clearance after exercise.Google Scholar
- 32.Earl K, Sakellariou G, Owens D, Sinclair M, Fenech M, Close G et al. The role of cytokines in muscle fatigue in patients with chronic fatigue syndrome (CFS). The FASEB J. 2015;29(1 Supplement).Google Scholar
- 35.Nijs J, Aelbrecht S, Meeus M, Van Oosterwijck J, Zinzen E, Clarys P. Tired of being inactive: a systematic literature review of physical activity, physiological exercise capacity and muscle strength in patients with chronic fatigue syndrome. Disabil Rehabil. 2011;33(17-18):1493–500.PubMedCrossRefGoogle Scholar
- 39.Dimauro I, Mercatelli N, Caporossi D. Exercise-induced ROS in heat shock proteins response. Free Radical Biology Med. 2016.Google Scholar
- 62.• Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci. 2016;113(37):E5472–80. The authors of this study reported a characteristic pattern of cellular hypometabolism characteristic of impaired mitochondrial function compared to normal subjects which has not been demonstrated in patients suffering from anxiety depression or disuse muscle deconditioning. The authors have proposed that their proteomic signature could provide the first objective test enabling a diagnosis of ME/CFS.Google Scholar
- 68.McCully K, Natelson B. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci (Lond). 1999;97:603 - 8.Google Scholar
- 82.• Debold EP. Potential molecular mechanisms underlying muscle fatigue mediated by reactive oxygen and nitrogen species. Front Physiol. 2015;6:239. This review highlights some of the recent efforts which may offer information on the underlying molecular basis of muscle fatigue, including increased O&NS. The author discusses that compelling evidence comes from studies showing that pre-treatment of intact muscle with ROS scavengers significantly attenuate O&NS and the development of fatigue. The author concludes that two important emerging sites are the regulatory protein troponin and the actin binding region of myosin.Google Scholar
- 95.Powers SK, Ji LL, Kavazis AN, Jackson MJ. Reactive oxygen species: impact on skeletal muscle. Compre Physiol. 2011;1(2):941–69.Google Scholar
- 103.Heunks LM, Machiels HA, Dekhuijzen PN, Prakash YS, Sieck GC. Nitric oxide affects sarcoplasmic calcium release in skeletal myotubes. J Appl Physiol (1985). 2001;91(5):2117–24.Google Scholar
- 111.Moon Y, Cao Y, Zhu J, Xu Y, Balkan W, Buys ES et al. GSNOR deficiency enhances in situ skeletal muscle strength, fatigue resistance and RyR1 S-nitrosylation without impacting mitochondrial content and activity. Antioxid Redox Signal. 2016.Google Scholar
- 128.Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, et al. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280(39):33588–98.PubMedCrossRefGoogle Scholar
- 134.Nunez M, Fernandez-Sola J, Nunez E, Fernandez-Huerta JM, Godas-Sieso T, Gomez-Gil E. Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up. Clin Rheumatol. 2011;30(3):381–9.PubMedCrossRefGoogle Scholar
- 135.Twisk FN, Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol Lett. 2009;30(3):284–99.PubMedGoogle Scholar